iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares / RAREi - The Canadian Forum for Rare Disease Innovators
Enregistrement :
10
de
11
(2024-05-03
à
2024-07-17)
Détails sur les objets indiqués
Objets
Détails
Catégories
Budget, Santé, Industrie
Bill C-64: An Act respecting pharmacare, with a particular focus on access to medicines and rare disease and orphan drug policies
Proposition législative, Projet de loi ou résolution
Budget, Santé, Industrie
Engagement with officials on issues related to the National Strategy for Rare Disease Drugs, and other policies or programs related to rare diseases.
Politique ou Programme
Budget, Santé, Industrie
Federally-funded public drug plans, with respect to reimbursement fof medicines for federal plan beneficiaries.
Politique ou Programme
Budget, Santé, Industrie
Federal programs and budgetary initiatives related to the Federal-Provincial-Territorial funding arrangements regarding pharmaceuticals including any health technology assessment-related or other policy discussions that might involve Health Canada and its ongoing relationship with the Canadian Agency for Drugs and Technologies in Health (CADTH), Canada's Drug Agency and/or other pan-Canadian health organizations.
Politique ou Programme
Budget, Santé, Industrie
Guidelines, policies and programs related to regulatory and reporting functions of the Patented Medicine Prices Review Board
Politique ou Programme, Règlement
Budget, Santé, Industrie, Recherche et développement, Sciences et technologies
Innovation, Science and Economic Development Canada regarding the Innovation and Skills Agenda, the Biomanufacturing and Life Sciences Strategy and other government policies and programs related to incentivizing research and development activities in Canada.
Politique ou Programme
Santé
Regulatory amendments and/or guidelines and/or policies related to the Food and Drugs Act and Health Canada review of drugs for rare diseases.